Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. - Wikidata - wikimedia - TriplyDB

Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review.

Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review.

http://www.wikidata.org/entity/Q35097757

about

Vitamin E Analogs as Radiation Response Modifiers Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures Chemistry and biology of vitamin E Tocotrienols are good adjuvants for developing cancer vaccines.Enhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity.Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.Protective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation.Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.Dietary antioxidants and human cancer.Chemotherapy and dietary phytochemical agents.The Combination of α-Tocopheryl Succinate and Sodium Selenite on Breast Cancer: A Merit or a Demerit?Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy Orally active alpha-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer.Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption.Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside?Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.Vitamin E Nicotinate.The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.Current state in the development of candidate therapeutic HPV vaccines Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy.Selenium compounds induced ROS-dependent apoptosis in myelodysplasia cells.Alpha-Tocopherol Alters Transcription Activities that Modulates Tumor Necrosis Factor Alpha (TNF-α) Induced Inflammatory Response in Bovine Cells Anticancer activity of vitamin E-derived compounds in murine C6 glioma cells.Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo.Heterogeneous effects of distinct tocopherol analogues on NO release, cell volume, and cell death in microglial cells.Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids.Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture.Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality.Alpha-Tocopherol Modulates Transcriptional Activities that Affect Essential Biological Processes in Bovine Cells.α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.

P2860

Q26781114-1DF63EF1-D0D4-4B2F-9611-FFF6AACF8429 Q28282070-ACB82F03-063E-4540-9CFF-2F127F1D9D09 Q28290335-795196E9-88D6-4570-9F6B-E360D577DE30 Q28296736-4305E176-0BC6-4FFD-A331-D96DF4404A0B Q33522067-0C560283-55EA-40F0-9587-BAE3ED354A80 Q33920277-6D0872C0-C992-4000-BD62-554A4F4F515C Q33968479-81E9F02B-665E-4BBB-B95B-D437FF42BD4D Q34276153-8D9B11E3-F510-4B55-98C0-11C19C582237 Q34546809-A4A77BBE-CE35-494A-A1A9-B77900B322B4 Q35182759-A293AE54-CC2A-4208-A491-DD9A97C7336F Q35689588-4B895512-901D-4C00-8002-2B05CAA8C34D Q35937789-34EDD9ED-9429-4261-88F8-874E930380D7 Q35937796-EA37FD69-DA2D-493C-801D-0AAF9FB7428B Q36516033-54C3E5C2-3ED9-4996-8059-E7FB271F8FC1 Q36805390-884AD740-5EB6-4F13-9E9F-FBFDAAD08DFD Q36883705-007CEF26-6FD3-4B41-A16B-E96334771B31 Q36957648-21089746-BF46-4483-B587-FFB5795AFAB7 Q36973037-3DEACCDA-BCE6-48AC-8B32-35817079E4AB Q37192084-5CAED180-2A5A-44CA-B09E-58A2FFEDC1E7 Q37346232-177698F2-5B56-4E8B-8014-2F51BAE0C6E6 Q37626466-7FD6621E-62CC-4B47-81F5-7AE51BCC2871 Q37741233-4E71A917-A60A-44EF-9B93-9C8AC7BE685A Q38173414-7E007E4A-7FBE-43E4-9F92-EA4FDB5C345D Q38743922-9D1CF6E2-02C6-43B9-AD2A-2DAE85BB17DF Q38974572-7258A283-6284-458F-BBAB-9CC9BF5A02F7 Q38975631-1A30D06B-2099-42DC-801A-5761D295DEAE Q39117707-FC2EFB88-3F87-43AB-85C6-6D88FB7C12EE Q39407945-DEA02A00-FBB0-4D51-ADCE-B39354E19DD6 Q39743131-C1AB446C-E04F-49EC-91AC-1312325DA6E8 Q39788042-C53276DC-4E2D-40E4-A4C6-E2901D1DEDC5 Q39949749-1E0C86A7-6B66-413B-AF6B-35256E4A6E27 Q40229191-81237C21-4F3F-425C-8C4A-9632AC6CD248 Q40354557-B375F8B6-742B-4F41-8AA6-4AA14109298F Q40393732-A255B3BA-B4A0-421D-9892-E1F99F7E1F2C Q40572647-2F6B6A9D-56A9-46A0-BF96-AF1F8F746658 Q40614433-DF47F8A5-1B68-4106-8334-FEF19E64B8F3 Q40701012-5FF71AE7-558D-4EBA-84F1-BA4CC445AAE2 Q41139234-665B666B-0C8D-4C5E-AE82-63ECEFD1216D Q42026315-F933D4FA-A33E-4C3D-BC65-CE9622231796 Q43235073-DF463525-4C81-4BC0-9BEA-ECFAE7438B3F

P2860

Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review.

http://www.wikidata.org/entity/Q35097757

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@ast

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@en

type

label

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@ast

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@en

prefLabel

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@ast

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@en

P1433

Q35097757-D7A88C3D-02CC-4283-BFDF-EBC12CC6EA4F

P1476

Q35097757-028A1FC1-F6C4-4C58-8D46-03138D4BB472

P2093

Q35097757-14009BD4-1033-4BD3-8BEB-44AF65ACEC71

Q35097757-80F88081-18BC-423A-9890-3EF45CF2D288

Q35097757-9C7E187A-5F37-4CA1-80DD-4648E2085F04

Q35097757-B77D9840-4A81-4DEF-9677-5F6699F84CB2

Q35097757-B8EE87FF-2562-4EAA-831B-D2C54831DFA9

P2860

Q35097757-0089772B-857F-4779-9D9C-271B9B678C72

Q35097757-0A289FE4-252A-456E-B508-815F5D13DBC3

Q35097757-1D6AC90F-01DA-416A-823A-7EC02B4A0795

Q35097757-325A0DDA-1737-4944-9010-51E4910408E5

Q35097757-3541B697-907E-4F8B-8D16-2FD4E1B4BB39

Q35097757-36ED8E6F-38CC-424D-83F5-793AC36940ED

Q35097757-37C1578A-EDE0-4D58-B23D-F915A1C0AA01

Q35097757-511F0F9C-CCE4-462C-9262-F9A5186C8591

Q35097757-521D48DA-0C29-4AF4-AA60-6A44A34EA92C

Q35097757-5543C754-AA2E-4954-A185-F43A49BA1FB1

P304

Q35097757-C4E79D60-5DFE-4B79-977B-E2CF1E67701E

P31

Q35097757-4A1374CF-DE3E-4FB6-ACBD-9F8C7B8CEC3F

P356

Q35097757-FD36BD55-4BE7-404E-BD88-4CBBA973001F

P433

Q35097757-C8914BDD-33EE-43BE-A835-7936A20676FD

P478

Q35097757-44F8059A-5AFB-4463-BB4D-CAF9CC0E2BBB

P577

Q35097757-F899FE9A-F0A4-4679-8478-26E8A4A5168B

P698

Q35097757-78AF4C13-63BB-4A9E-8208-2B468EBE31D5

P356

07315724.2003.10719283

P1433

Journal of the American College of Nutrition

P1476

Alpha-tocopheryl succinate, th ...... nt cancer treatment: a review.

@en

P2093

Amy J Hanson

http://www.w3.org/2001/XMLSchema#string

Bipin Kumar

http://www.w3.org/2001/XMLSchema#string

Kedar N Prasad

http://www.w3.org/2001/XMLSchema#string

William C Cole

http://www.w3.org/2001/XMLSchema#string

Xiang-Dong Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Selective cancer cell killing by alpha-tocopheryl succinate

Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms

Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements.

d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties.

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells

Alpha-tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversion.

ON THE EXISTENCE OF A HITHERTO UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION.

Vitamin E and cancer prevention: recent advances and future potentials.

RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest.

Role of vitamin E in the prophylaxis of cancer.

P304

108-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07315724.2003.10719283

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12672706

http://www.w3.org/2001/XMLSchema#string